Additionally, recent findings suggest GPR3 activity is linked to amyloidogenic proteolysis of amyloid-β precursor protein (APP) and its loss of activity is connected with memory improvement in AD transgenic (ADtg) mouse models (Huang et al., 2015). This evidence concerns the gene APP and Alzheimer disease.